Αποτελέσματα αναζήτησης - Richmond, Gary

Intraspecific variation in thermal acclimation and tolerance between populations of the winter ant, Prenolepis imparis από Tonione, Maria Adelena, Cho, So Mi, Richmond, Gary, Irian, Christian, Tsutsui, Neil Durie

Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου

Forty-eight-Week Safety and Efficacy On-Treatment Analysis of Ibalizumab in Patients with Multi-Drug Resistant HIV-1 από Emu, Brinda, Fessel, W Jeffery, Schrader, Shannon, Kumar, Princy N, Richmond, Gary, Win, Sandra, Weinheimer, Steven, Marsolais, Christian, Lewis, Stanley

Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου

Twice-daily amprenavir 1200 mg versus amprenavir 600 mg/ritonavir 100 mg, in combination with at least 2 other antiretroviral drugs, in HIV-1-infected patients από Nadler, Jeffrey P, Gathe, Joseph C, Pollard, Richard B, Richmond, Gary J, Liao, Qiming, Griffith, Sandy, Tracey Lancaster, C, Hernandez, Jaime E, Pappa, Keith A

Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου

Sword 1 and 2: Subgroup Analysis of 48 Week Results by Age, Race and Gender από Walmsley, Sharon, Richmond, Gary, Bredeek, Fritz, Ramgopal, Moti, Hung, Chien-Ching, Blair, Elizabeth, Kahl, Lesley, Underwood, Mark, Angelis, Kostas, Vandermeulen, Kati, Wynne, Brian, Aboud, Michael

Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου

Experiences with long acting injectable ART: A qualitative study among PLHIV participating in a Phase II study of cabotegravir + rilpivirine (LATTE-2) in the United States and Spai... από Kerrigan, Deanna, Mantsios, Andrea, Gorgolas, Miguel, Montes, Maria-Luisa, Pulido, Federico, Brinson, Cynthia, deVente, Jerome, Richmond, Gary J., Beckham, S. Wilson, Hammond, Paige, Margolis, David, Murray, Miranda

Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου

116. Antiviral Activity and Safety of Long-acting Cabotegravir (CAB LA) Plus Long-acting Rilpivirine (RPV LA), Administered Every 2 Months (Q2M), in Hiv-positive Subjects: Results... από Mills, Anthony, Richmond, Gary J, Newman, Cheryl, Osiyemi, Olayemi, Cade, Jerry, Brinson, Cynthia, De Vente, Jerome, Andany, Nisha, Margolis, David, Sutton, Kenneth, Wilches, Viviana, Roberts, Jeremy, McCoig, Cynthia C, Vandermeulen, Kati, Spreen, William

Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου

Long-acting cabotegravir and rilpivirine for HIV-1 suppression: switch to 2-monthly dosing after 5 years of daily oral therapy από Mills, Anthony, Richmond, Gary J., Newman, Cheryl, Osiyemi, Olayemi, Cade, Jerry, Brinson, Cynthia, De Vente, Jerome, Margolis, David A., Sutton, Kenneth C., Wilches, Viviana, Hatch, Sarah, Roberts, Jeremy, McCoig, Cynthia, Garris, Cindy, Vandermeulen, Kati, Spreen, William R.

Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου

Efficacy, Safety, and Durability of Long-Acting Cabotegravir and Rilpivirine in Adults With Human Immunodeficiency Virus Type 1 Infection: 5-Year Results From the LATTE-2 Study από Smith, Graham H R, Henry, W Keith, Podzamczer, Daniel, Masiá, Maria Del Mar, Bettacchi, Christopher J, Arasteh, Keikawus, Jaeger, Hans, Khuong-Josses, Marie-Aude, Montes-Ramírez, Maria Luisa, Stellbrink, Hans-Jürgen, Yazdanpanah, Yazdan, Richmond, Gary J, Sutton, Kenneth C, Zhang, Feifan, McCoig, Cynthia C, St Clair, Marty H, Vandermeulen, Kati, Van Solingen-Ristea, Rodica, Smith, Kimberly Y, Margolis, David A, Spreen, William R

Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου

Safety and Efficacy of Dolutegravir in Treatment-Experienced Subjects With Raltegravir-Resistant HIV Type 1 Infection: 24-Week Results of the VIKING Study από Eron, Joseph J., Clotet, Bonaventura, Durant, Jacques, Katlama, Christine, Kumar, Princy, Lazzarin, Adriano, Poizot-Martin, Isabelle, Richmond, Gary, Soriano, Vincent, Ait-Khaled, Mounir, Fujiwara, Tamio, Huang, Jenny, Min, Sherene, Vavro, Cindy, Yeo, Jane, Walmsley, Sharon L., Cox, Joseph, Reynes, Jacques, Morlat, Philippe, Vittecoq, Daniel, Livrozet, Jean-Michel, Fernández, Pompeyo Viciana, Gatell, Jose M., DeJesus, Edwin, DeVente, Jerome, Lalezari, Jacob P., McCurdy, Lewis H., Sloan, Louis A., Young, Benjamin, LaMarca, Anthony, Hawkins, Trevor

Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου

Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials από Rizzardini, Giuliano, Overton, Edgar T., Orkin, Chloe, Swindells, Susan, Arasteh, Keikawus, Górgolas Hernández-Mora, Miguel, Pokrovsky, Vadim, Girard, Pierre-Marie, Oka, Shinichi, Andrade-Villanueva, Jaime F., Richmond, Gary J., Baumgarten, Axel, Masiá, Mar, Latiff, Gulam, Griffith, Sandy, Harrington, Conn M., Hudson, Krischan J., St. Clair, Marty, Talarico, Christine L., Patel, Parul, Cutrell, Amy, Van Eygen, Veerle, D'Amico, Ronald, Mrus, Joseph M., Wu, Sterling, Ford, Susan L., Chow, Ken, Roberts, Jeremy, Wills, Angela, Walters, Nicola, Vanveggel, Simon, Van Solingen-Ristea, Rodica, Crauwels, Herta, Smith, Kimberly Y., Spreen, William R., Margolis, David A.

Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου